Ohmic Biosciences

Startup
Summarized by Halo AI

Ohmic Biosciences is an agricultural biotech company that utilizes protein engineering and synthetic biology to create disease-resistant crops, helping farmers protect yields against evolving agricultural pathogens.

Founded & HQ
San Francisco, CA, USA
Company size
1-10 employees
Funding
~$500K
Activity highlights
Participated in the Y Combinator Summer 2023 batch to scale its protein engineering and synthetic biology platform for crop disease resistance.

Ohmic Biosciences is an agricultural biotechnology company that uses protein engineering and synthetic biology to develop disease-resistant crops. Founded in 2021 by PJ Steiner and Matthew Bedewitz, the company designs custom resistance genes to inhibit the effector proteins used by pathogens to infect plants. By moving away from traditional breeding and agrochemical reliance, the company aims to create durable, engineered traits that remain effective against evolving pathogens.

This approach addresses the significant economic losses caused by plant diseases, such as the soybean cyst nematode, which causes billions of dollars in annual damage. By providing robust, genetically-engineered protection, Ohmic Biosciences seeks to offer a more reliable solution for large-scale industrial agriculture than existing chemical interventions or conventional breeding methods. The company is backed by investors including Y Combinator and Climate Capital.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.